Short Interest in Henry Schein, Inc. (NASDAQ:HSIC) Decreases By 8.7%

Henry Schein, Inc. (NASDAQ:HSIC) was the recipient of a significant decrease in short interest during the month of November. As of November 15th, there was short interest totalling 6,210,000 shares, a decrease of 8.7% from the October 31st total of 6,800,000 shares. Approximately 5.1% of the company’s stock are short sold. Based on an average daily volume of 1,730,000 shares, the short-interest ratio is currently 3.6 days.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. UBS Group reduced their price target on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. Robert W. Baird decreased their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. JPMorgan Chase & Co. dropped their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research report on Monday, August 12th. Evercore ISI lifted their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Finally, StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Six investment analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Henry Schein has a consensus rating of “Moderate Buy” and a consensus target price of $79.38.

Henry Schein Stock Down 1.7 %

HSIC stock opened at $75.21 on Wednesday. The stock has a market cap of $9.38 billion, a PE ratio of 30.95, a price-to-earnings-growth ratio of 2.20 and a beta of 0.87. The firm’s 50-day simple moving average is $71.66 and its 200 day simple moving average is $69.89. Henry Schein has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.17 by $0.05. The company had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue was up .4% compared to the same quarter last year. During the same quarter last year, the business earned $1.32 earnings per share. As a group, sell-side analysts predict that Henry Schein will post 4.78 EPS for the current year.

Insider Activity at Henry Schein

In related news, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the sale, the chief operating officer now directly owns 87,706 shares of the company’s stock, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the transaction, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. This trade represents a 22.65 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. American Century Companies Inc. raised its stake in shares of Henry Schein by 3.1% during the second quarter. American Century Companies Inc. now owns 5,484,286 shares of the company’s stock valued at $351,543,000 after purchasing an additional 162,477 shares in the last quarter. FMR LLC increased its stake in Henry Schein by 7.8% during the 3rd quarter. FMR LLC now owns 3,280,890 shares of the company’s stock valued at $239,177,000 after buying an additional 237,888 shares during the period. Southpoint Capital Advisors LP raised its position in shares of Henry Schein by 30.0% during the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock worth $189,540,000 after buying an additional 600,000 shares in the last quarter. Nuance Investments LLC lifted its stake in shares of Henry Schein by 22.3% in the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after acquiring an additional 414,748 shares during the period. Finally, Burgundy Asset Management Ltd. boosted its holdings in shares of Henry Schein by 1.0% in the second quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company’s stock valued at $105,148,000 after acquiring an additional 16,476 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.